{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:49:42Z","timestamp":1790862582665,"version":"4.1.0"},"reference-count":137,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Center of Excellence on Medical Biotechnology (CEMB), S&amp;T Postgraduate Education and Research Development Office (PERDO), Office of Higher Education Commission (OHEC), Thailand","award":["-"],"award-info":[{"award-number":["-"]}]},{"name":"Annual Budget Grant  of Mahidol University","award":["B.E. 2557-2559"],"award-info":[{"award-number":["B.E. 2557-2559"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>\u03b2-Lactams are the most widely used and effective antibiotics for the treatment of infectious diseases. Unfortunately, bacteria have developed several mechanisms to combat these therapeutic agents. One of the major resistance mechanisms involves the production of \u03b2-lactamase that hydrolyzes the \u03b2-lactam ring thereby inactivating the drug. To overcome this threat, the small molecule \u03b2-lactamase inhibitors (e.g., clavulanic acid, sulbactam and tazobactam) have been used in combination with \u03b2-lactams for treatment. However, the bacterial resistance to this kind of combination therapy has evolved recently. Therefore, multiple attempts have been made to discover and develop novel broad-spectrum \u03b2-lactamase inhibitors that sufficiently work against \u03b2-lactamase producing bacteria. \u03b2-lactamase inhibitory proteins (BLIPs) (e.g., BLIP, BLIP-I and BLIP-II) are potential inhibitors that have been found from soil bacterium Streptomyces spp. BLIPs bind and inhibit a wide range of class A \u03b2-lactamases from a diverse set of Gram-positive and Gram-negative bacteria, including TEM-1, PC1, SME-1, SHV-1 and KPC-2. To the best of our knowledge, this article represents the first systematic review on \u03b2-lactamase inhibitors with a particular focus on BLIPs and their inherent properties that favorably position them as a source of biologically-inspired drugs to combat antimicrobial resistance. Furthermore, an extensive compilation of binding data from \u03b2-lactamase\u2013BLIP interaction studies is presented herein. Such information help to provide key insights into the origin of interaction that may be useful for rationally guiding future drug design efforts.<\/jats:p>","DOI":"10.3390\/ijms19082222","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T11:55:08Z","timestamp":1532951708000},"page":"2222","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Tackling the Antibiotic Resistance Caused by Class A \u03b2-Lactamases through the Use of \u03b2-Lactamase Inhibitory Protein"],"prefix":"10.3390","volume":"19","author":[{"given":"Warawan","family":"Eiamphungporn","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Schaduangrat","sequence":"additional","affiliation":[{"name":"Center of Data Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz Ahmad","family":"Malik","sequence":"additional","affiliation":[{"name":"Center of Data Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-663X","authenticated-orcid":false,"given":"Chanin","family":"Nantasenamat","sequence":"additional","affiliation":[{"name":"Center of Data Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2018, June 15). Antibiotic Resistance. Available online: http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/antibiotic-resistance."},{"key":"ref_2","unstructured":"O\u2019Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations, Wellcome Trust. Review on Antimicrobial Resistance."},{"key":"ref_3","unstructured":"O\u2019Neill, J. (2015). Securing New Drugs for Future Generations: The Pipeline of Antibiotics, Wellcome Trust. Review on Antimicrobial Resistance."},{"key":"ref_4","unstructured":"World Health Organization (2018, June 15). Antimicrobial Resistance. Available online: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","article-title":"Antibiotic resistance and extended spectrum \u03b2-lactamases: Types, epidemiology and treatment","volume":"22","author":"Shaikh","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1080\/10408398.2015.1077192","article-title":"Antimicrobial resistance: A global emerging threat to public health systems","volume":"57","author":"Ferri","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.mib.2005.08.016","article-title":"\u03b2-lactam antibiotic resistance: A current structural perspective","volume":"8","author":"Wilke","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40265-017-0725-1","article-title":"Novel beta-lactamase inhibitors: Unlocking their potential in therapy","volume":"77","author":"Wong","year":"2017","journal-title":"Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-6976.2007.00099.x","article-title":"Bacterial peptidoglycan (murein) hydrolases","volume":"32","author":"Vollmer","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.molcel.2012.09.016","article-title":"Distinct single-cell morphological dynamics under \u03b2-lactam antibiotics","volume":"48","author":"Yao","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/pro.2889","article-title":"One ring to rule them all: Current trends in combating bacterial resistance to the \u03b2-lactams","volume":"25","author":"King","year":"2016","journal-title":"Protein Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0923-2508(91)90084-N","article-title":"Diversity of the mechanisms of resistance to \u03b2-lactam antibiotics","volume":"142","author":"Joris","year":"1991","journal-title":"Res. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9688","DOI":"10.1021\/bi1012222","article-title":"Structural relationship between the active sites of \u03b2-lactam-recognizing and amidase signature enzymes: Convergent evolution?","volume":"49","author":"Pratt","year":"2010","journal-title":"Biochemistry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/protein\/14.7.487","article-title":"Protein minimization by random fragmentation and selection","volume":"14","author":"Rudgers","year":"2001","journal-title":"Protein Eng."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: Historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.08.003","article-title":"Mechanisms of \u03b2-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria","volume":"78","author":"Tang","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/0929867023370031","article-title":"Resistance to \u03b2-lactam antibiotics: structure and mechanism based design of \u03b2-lactamase inhibitors","volume":"9","author":"Sandanayaka","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"ref_19","first-page":"321","article-title":"The structure of \u03b2-lactamases","volume":"289","author":"Ambler","year":"1980","journal-title":"Philos. Trans. R. Soc. B"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for \u03b2-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bonomo, R.A. (2017). \u03b2-Lactamases: A focus on current challenges. Cold Spring Harb. Perspect. Med., 7.","DOI":"10.1101\/cshperspect.a025239"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: An emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: A clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/0974-777X.68531","article-title":"Extended-spectrum \u03b2-lactamases in Gram negative bacteria","volume":"2","author":"Rawat","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum \u03b2-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of \u03b2-lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9519718","DOI":"10.1155\/2018\/9519718","article-title":"The growing genetic and functional diversity of extended spectrum \u03b2-lactamases","volume":"2018","author":"Rahman","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"9185","DOI":"10.1021\/bi9007963","article-title":"Structural and biochemical characterization of the interaction between KPC-2 \u03b2-lactamase and \u03b2-lactamase inhibitor protein","volume":"48","author":"Hanes","year":"2009","journal-title":"Biochemistry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/1040841X.2012.691460","article-title":"Epidemiology and genetics of CTX-M extended-spectrum \u03b2-lactamases in Gram-negative bacteria","volume":"39","author":"Zhao","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0924-8579(99)00165-X","article-title":"CTX-M-type \u03b2-lactamases: An emerging group of extended-spectrum enzymes","volume":"14","author":"Tzouvelekis","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: The versatile \u03b2-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Poirel","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","article-title":"The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide","volume":"20","author":"Nordmann","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1128\/AAC.48.7.2347-2349.2004","article-title":"Update of the standard numbering scheme for class B \u03b2-lactamases","volume":"48","author":"Garau","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/138920309789351967","article-title":"Three decades of the class A \u03b2-lactamase acyl-enzyme","volume":"10","author":"Fisher","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2012.06796.x","article-title":"Metallo-\u03b2-lactamase structure and function","volume":"1277","author":"Palzkill","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of \u03b2-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/CMR.18.2.306-325.2005","article-title":"Metallo-\u03b2-lactamases: The quiet before the storm?","volume":"18","author":"Walsh","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_40","first-page":"297","article-title":"Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics","volume":"8","author":"Zmarlicka","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-\u03b2-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Khan, A.U., Maryam, L., and Zarrilli, R. (2017). Structure, genetics and worldwide spread of New Delhi metallo-\u03b2-lactamase (NDM): A threat to public health. BMC Microbiol., 17.","DOI":"10.1186\/s12866-017-1012-8"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1021\/bi971056h","article-title":"Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-\u03b2-lactamase activity and stability","volume":"36","author":"Felici","year":"1997","journal-title":"Biochemistry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1367-5931(99)00017-4","article-title":"Metallo-\u03b2-lactamase: Structure and mechanism","volume":"3","author":"Wang","year":"1999","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","article-title":"Plasmid-determined AmpC-type \u03b2-lactamases","volume":"46","author":"Philippon","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC \u03b2-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1590\/S1517-83822010000300009","article-title":"AmpC \u03b2-lactamases among Gram negative clinical isolates from a tertiary hospital, South India","volume":"41","author":"Harish","year":"2010","journal-title":"Brazil. J. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/JCM.00219-10","article-title":"Extended-spectrum-\u03b2-lactamase, AmpC, and carbapenemase issues","volume":"48","author":"Thomson","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.78.8.4897","article-title":"ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of \u03b2-lactamases of the penicillinase type","volume":"78","author":"Jaurin","year":"1981","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2010621","article-title":"Active sites of \u03b2-lactamases. The chromosomal \u03b2-lactamases of Pseudomonas aeruginosa and Escherichia coli","volume":"201","author":"Petursson","year":"1982","journal-title":"Biochem. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/AAC.00826-13","article-title":"New \u03b2-lactamase inhibitors: A therapeutic renaissance in an MDR world","volume":"58","author":"Drawz","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1021\/ja056806m","article-title":"The deacylation mechanism of AmpC \u03b2-lactamase at ultrahigh resolution","volume":"128","author":"Chen","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.01512-08","article-title":"Diversity, epidemiology, and genetics of class D \u03b2-lactamases","volume":"54","author":"Poirel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/antibiotics3030398","article-title":"Acquired class D \u03b2-lactamases","volume":"3","author":"Antunes","year":"2014","journal-title":"Antibiotics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1128\/AAC.02522-13","article-title":"Class D \u03b2-lactamases: Are they all carbapenemases?","volume":"58","author":"Antunes","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/CMR.00117-13","article-title":"OXA \u03b2-lactamases","volume":"27","author":"Evans","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Smith, C.A., Antunes, N.T., Stewart, N.K., Toth, M., Kumarasiri, M., Chang, M., Mobashery, S., and Vakulenko, S.B. (2013). Structural basis for carbapenemase activity of the OXA-23 \u03b2-lactamase from Acinetobacter baumannii. Chem. Biol., 20.","DOI":"10.1016\/j.chembiol.2013.07.015"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.11.5.852","article-title":"Clavulanic acid: A beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus","volume":"11","author":"Reading","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/AAC.14.3.414","article-title":"CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: Initial bacteriological characterization","volume":"14","author":"English","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1098\/rstb.1980.0048","article-title":"\u03b2-lactamase inactivation by mechanism-based reagents","volume":"289","author":"Fisher","year":"1980","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.ijantimicag.2007.07.015","article-title":"Introduction: Historical perspective and development of amoxicillin\/clavulanate","volume":"30","author":"Geddes","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bcp.2005.11.012","article-title":"Understanding the longevity of the \u03b2-lactam antibiotics and of antibiotic\/\u03b2-lactamase inhibitor combinations","volume":"71","author":"Buynak","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-5793(93)80692-N","article-title":"Interaction of clavulanate with class C \u03b2-lactamases","volume":"334","author":"Monnaie","year":"1993","journal-title":"FEBS Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1054\/drup.2000.0137","article-title":"\u03b2-lactamase inhibitors","volume":"3","author":"Page","year":"2000","journal-title":"Drug Resist. Updat."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.38.4.767","article-title":"Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important \u03b2-lactamases","volume":"38","author":"Payne","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jac\/dkh358","article-title":"In vitro activity of AVE1330A, an innovative broad-spectrum non-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"54","author":"Bonnefoy","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent, reversible, non-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"109","author":"Ehmann","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4155\/fmc-2016-0078","article-title":"The road to avibactam: The first clinically useful non-\u03b2-lactam working somewhat like a \u03b2-lactam","volume":"8","author":"Wang","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Temkin, E., Torre-Cisneros, J., Beovic, B., Benito, N., Giannella, M., Gilarranz, R., Jeremiah, C., Loeches, B., Machuca, I., and Jim\u00e9nez-Mart\u00edn, M.J. (2017). Ceftazidime-Avibactam as salvage therapy for infections caused by carbapenem-resistant organisms. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.01964-16"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1128\/AAC.03057-14","article-title":"Avibactam and class C \u03b2-lactamases: Mechanism of inhibition, conservation of the binding pocket, and implications for resistance","volume":"58","author":"Lahiri","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2017.11.002","article-title":"An update on \u03b2-lactamase inhibitor discovery and development","volume":"36","author":"Docquier","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/pro.3100","article-title":"Exploring the potential of boronic acids as inhibitors of OXA-24\/40 \u03b2-lactamase","volume":"26","author":"Werner","year":"2017","journal-title":"Protein Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1074-5521(00)00052-1","article-title":"Energetic, structural, and antimicrobial analyses of \u03b2-lactam side chain recognition by \u03b2-lactamases","volume":"8","author":"Caselli","year":"2001","journal-title":"Chem. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"10504","DOI":"10.1021\/ja001676x","article-title":"Crystal structures of substrate and inhibitor complexes with AmpC \u03b2-lactamase: Possible implications for substrate-assisted catalysis","volume":"122","author":"Patera","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1038\/ncomms12406","article-title":"Structural basis of metallo-\u03b2-lactamase, serine-\u03b2-lactamase and penicillin-binding protein inhibition by cyclic boronates","volume":"7","author":"Brem","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Cahill, S.T., Cain, R., Wang, D.Y., Lohans, C.T., Wareham, D.W., Oswin, H.P., Mohammed, J., Spencer, J., Fishwick, C.W.G., McDonough, M.A., Schofielda, C.J., and Brem, J. (2017). Cyclic boronates inhibit all classes of \u03b2-lactamases. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.02260-16"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1021\/ja104092z","article-title":"Design, synthesis, and crystal structures of 6-alkylidene-2\u2019-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase","volume":"132","author":"Bou","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/AAC.00743-09","article-title":"Penicillin sulfone inhibitors of class D \u03b2-lactamases","volume":"54","author":"Drawz","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/07391102.2013.789988","article-title":"Structure-based screening of inhibitors against KPC-2: Designing potential drug candidates against multidrug-resistant bacteria","volume":"32","author":"Danishuddin","year":"2014","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mib.2017.10.026","article-title":"Inhibitors of metallo-\u03b2-lactamases","volume":"39","author":"Rotondo","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1021\/acsinfecdis.7b00094","article-title":"Thiol-containing metallo-\u03b2-lactamase inhibitors resensitize resistant Gram-negative bacteria to meropenem","volume":"3","author":"Tehrani","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1039\/C6SC04524C","article-title":"NMR-filtered virtual screening leads to non-metal chelating metallo-\u03b2-lactamase inhibitors","volume":"8","author":"Li","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1021\/acs.biochem.7b01299","article-title":"Structural and kinetic studies of the potent inhibition of metallo-\u03b2-lactamases by 6-phosphonomethylpyridine-2-carboxylates","volume":"57","author":"Hinchliffe","year":"2018","journal-title":"Biochemistry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/acsinfecdis.7b00243","article-title":"Game changers: New \u03b2-lactamase inhibitor combinations targeting antibiotic resistance in Gram-negative bacteria","volume":"4","author":"Bush","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1128\/jb.172.9.4909-4918.1990","article-title":"Isolation and characterization of a \u03b2-lactamase-inhibitory protein from Streptomyces clavuligerus and cloning and analysis of the corresponding gene","volume":"172","author":"Doran","year":"1990","journal-title":"J. Bacteriol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/368657a0","article-title":"Structural and kinetic characterization of a \u03b2-lactamase-inhibitor protein","volume":"368","author":"Strynadka","year":"1994","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/acsinfecdis.6b00160","article-title":"Engineering specificity from broad to narrow: Design of a \u03b2-lactamase inhibitory protein (BLIP) variant that exclusively binds and detects KPC \u03b2-lactamase","volume":"2","author":"Chow","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"45706","DOI":"10.1074\/jbc.M308572200","article-title":"Determinants of binding affinity and specificity for the interaction of TEM-1 and SME-1 \u03b2-lactamase with \u03b2-lactamase inhibitory protein","volume":"278","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nsb0396-233","article-title":"Molecular docking programs successfully predict the binding of a \u03b2-lactamase inhibitory protein to TEM-1 \u03b2-lactamase","volume":"3","author":"Strynadka","year":"1996","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1074\/jbc.274.4.2394","article-title":"Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of \u03b2-lactamases","volume":"274","author":"Petrosino","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/76744","article-title":"Rational design of faster associating and tighter binding protein complexes","volume":"7","author":"Selzer","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmbi.1998.1843","article-title":"Anatomy of hot spots in protein interfaces","volume":"280","author":"Bogan","year":"1998","journal-title":"J. Mol. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Adamski, C.J., and Palzkill, T. (2017). Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A \u03b2-lactamases. BMC Biochem., 18.","DOI":"10.1186\/s12858-017-0077-1"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"16851","DOI":"10.1074\/jbc.M000227200","article-title":"New \u03b2-lactamase inhibitory protein (BLIP-I) from Streptomyces exfoliatus SMF19 and its roles on the morphological differentiation","volume":"275","author":"Kang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nsb1001-848","article-title":"Crystal structure and kinetic analysis of \u03b2-lactamase inhibitor protein-II in complex with TEM-1 \u03b2-lactamase","volume":"8","author":"Lim","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1128\/jb.179.6.2053-2059.1997","article-title":"A regulatory gene (ccaR) required for cephamycin and clavulanic acid production in Streptomyces clavuligerus: Amplification results in overproduction of both \u03b2-lactam compounds","volume":"179","author":"Liras","year":"1997","journal-title":"J. Bacteriol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jmb.2009.03.058","article-title":"Insights into positive and negative requirements for protein-protein interactions by crystallographic analysis of the \u03b2-lactamase inhibitory proteins BLIP, BLIP-I, and BLP","volume":"389","author":"Gretes","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1128\/aem.60.3.1029-1032.1994","article-title":"Characteristics of \u03b2-lactamase-inhibiting proteins from Streptomyces exfoliatus SMF19","volume":"60","author":"Kim","year":"1994","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/AAC.42.11.2893","article-title":"Display of functional \u03b2-lactamase inhibitory protein on the surface of M13 bacteriophage","volume":"42","author":"Huang","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/bi981772z","article-title":"Biophysical Characterization of the Interaction of the \u03b2-Lactamase TEM-1 with its protein inhibitor BLIP","volume":"38","author":"Albeck","year":"1999","journal-title":"Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"14964","DOI":"10.1074\/jbc.M001285200","article-title":"Design of potent \u03b2-lactamase inhibitors by phage display of \u03b2-lactamase inhibitory protein","volume":"275","author":"Huang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1074\/jbc.274.11.6963","article-title":"Identification of residues in \u03b2-lactamase critical for binding \u03b2-lactamase inhibitory protein","volume":"274","author":"Rudgers","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.46.11.3568-3573.2002","article-title":"Resistance to \u03b2-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM \u03b2-lactamase mutants","volume":"46","author":"Schroeder","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"42860","DOI":"10.1074\/jbc.M406157200","article-title":"Dissecting the protein-protein interface between \u03b2-lactamase inhibitory protein and class A \u03b2-lactamases","volume":"279","author":"Zhang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/protein\/gzq017","article-title":"Identification and characterization of \u03b2-lactamase inhibitor protein-II (BLIP-II) interactions with \u03b2-lactamases using phage display","volume":"23","author":"Brown","year":"2010","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nsb0396-290","article-title":"A potent new mode of \u03b2-lactamase inhibition revealed by the 1.7 \u00c5 X-ray crystallographic structure of the TEM-1-BLIP complex","volume":"3","author":"Strynadka","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/pro.2505","article-title":"Role of \u03b2-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II","volume":"23","author":"Fryszczyn","year":"2014","journal-title":"Protein Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1128\/AAC.00215-13","article-title":"BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2)","volume":"57","author":"Brown","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"14982","DOI":"10.1073\/pnas.1613122113","article-title":"Low-stringency selection of TEM1 for BLIP shows interface plasticity and selection for faster binders","volume":"113","author":"Schreiber","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Cohen-Khait, R., and Schreiber, G. (2018). Selecting for fast protein-protein association as demonstrated on a random TEM1 yeast library binding BLIP. Biochemistry.","DOI":"10.1021\/acs.biochem.8b00172"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1110\/ps.041283105","article-title":"Action-at-a-distance interactions enhance protein binding affinity","volume":"14","author":"Joughin","year":"2005","journal-title":"Protein Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/prot.1139","article-title":"New insights into the mechanism of protein-protein association","volume":"45","author":"Selzer","year":"2001","journal-title":"Proteins"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.compbiolchem.2012.12.002","article-title":"Communication between the active site and the allosteric site in class A \u03b2-lactamases","volume":"43","author":"Meneksedag","year":"2013","journal-title":"Computat. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Kanlikilicer, P., Ozkirimli Olmez, E., Budeyri, N., and Akbulut, B.S. (2010, January 20\u201322). Investigation of TEM-1 and SHV-1 \u03b2-lactamase ligand binding. Proceedings of the 5th International Symposium on Health Informatics and Bioinformatics, Antalya, Turkey.","DOI":"10.1109\/HIBIT.2010.5478885"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/prot.24574","article-title":"Detecting protein atom correlations using correlation of probability of recurrence","volume":"82","author":"Fataftah","year":"2014","journal-title":"Proteins"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jmb.2003.12.008","article-title":"Effect of crowding on protein-protein association rates: Fundamental differences between low and high mass crowding agents","volume":"336","author":"Kozer","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jbiotec.2003.12.004","article-title":"An efficient heat-inducible Bacillus subtilis bacteriophage 105 expression and secretion system for the production of the Streptomyces clavuligerus \u03b2-lactamase inhibitory protein (BLIP)","volume":"108","author":"Liu","year":"2004","journal-title":"J. Biotechnol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"26745","DOI":"10.1074\/jbc.M603878200","article-title":"Structural and computational characterization of the SHV-1 \u03b2-lactamase-\u03b2-lactamase inhibitor protein interface","volume":"281","author":"Reynolds","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmb.2007.05.032","article-title":"On the dynamic nature of the transition state for protein-protein association as determined by double-mutant cycle analysis and simulation","volume":"371","author":"Harel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"17676","DOI":"10.1074\/jbc.M611548200","article-title":"Thermodynamic investigation of the role of contact residues of \u03b2-lactamase-inhibitory protein for binding to TEM-1 \u03b2-lactamase","volume":"282","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jmb.2008.05.051","article-title":"Computational redesign of the SHV-1 \u03b2-lactamase\/\u03b2-lactamase inhibitor protein interface","volume":"382","author":"Reynolds","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1074\/jbc.M804089200","article-title":"Structural insight into the kinetics and DeltaCp of interactions between TEM-1 \u03b2-lactamase and \u03b2-lactamase inhibitory protein (BLIP)","volume":"284","author":"Wang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jmb.2009.04.028","article-title":"Fine mapping of the sequence requirements for binding of \u03b2-lactamase inhibitory protein (BLIP) to TEM-1 \u03b2-lactamase using a genetic screen for BLIP function","volume":"389","author":"Yuan","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/pro.467","article-title":"Protein-protein binding affinities by pulse proteolysis: Application to TEM-1\/BLIP protein complexes","volume":"19","author":"Hanes","year":"2010","journal-title":"Protein Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"32723","DOI":"10.1074\/jbc.M111.265058","article-title":"Analysis of the binding forces driving the tight interactions between \u03b2-Lactamase inhibitory protein-II (BLIP-II) and class A \u03b2-Lactamases","volume":"286","author":"Brown","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/protein\/gzr043","article-title":"Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions","volume":"24","author":"Fryszczyn","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/prot.22961","article-title":"Specificity and cooperativity at \u03b2-lactamase position 104 in TEM-1\/BLIP and SHV-1\/BLIP interactions","volume":"79","author":"Hanes","year":"2011","journal-title":"Proteins"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jmb.2011.01.014","article-title":"Identification of a \u03b2-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 \u03b2-lactamase","volume":"406","author":"Yuan","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1073\/pnas.1112171109","article-title":"Protein-binding dynamics imaged in a living cell","volume":"109","author":"Phillip","year":"2012","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bpj.2012.08.009","article-title":"Contrasting factors on the kinetic path to protein complex formation diminish the effects of crowding agents","volume":"103","author":"Phillip","year":"2012","journal-title":"Biophys. J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/psc.2739","article-title":"A novel chimeric peptide with antimicrobial activity","volume":"21","author":"Alaybeyoglu","year":"2015","journal-title":"J. Pept. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"De Kraker, M.E.A., Stewardson, A.J., and Harbarth, S. (2016). Will 10 million people die a year due to antimicrobial resistance by 2050?. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002184"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.biotechadv.2018.01.004","article-title":"Designing improved active peptides for therapeutic approaches against infectious diseases","volume":"36","author":"Gomes","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Sable, R., Parajuli, P., and Jois, S. (2017). Peptides, peptidomimetics, and polypeptides from marine sources: A wealth of natural sources for pharmaceutical applications. Mar. Drugs, 15.","DOI":"10.3390\/md15040124"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2012.03.003","article-title":"Carbapenem resistance in Enterobacteriaceae: Here is the storm!","volume":"18","author":"Nordmann","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20061100","article-title":"Cell-penetrating peptides and antimicrobial peptides: How different are they?","volume":"399","author":"Henriques","year":"2006","journal-title":"Biochem. J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1517\/17460441.2015.1016497","article-title":"Maximizing computational tools for successful drug discovery","volume":"10","author":"Nantasenamat","year":"2015","journal-title":"Expert Opin. Drug Discov."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2222\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:15:15Z","timestamp":1760195715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":137,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["ijms19082222"],"URL":"https:\/\/doi.org\/10.3390\/ijms19082222","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]}}}